Press Releases

Share
and/or
489 News Releases found
Selwyn M. Vickers
Dr. Selwyn M. Vickers Joins Memorial Sloan Kettering Cancer Center as President and CEO
Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has joined the institution as President and Chief Executive Officer.
Jonathan E. Rosenberg, MD
ESMO 2022: Research Reveals Promising New Combination Treatment for Bladder Cancer Patients
Nearly two thirds of patients who were treated with the combination enfortumab vedotin plus pembrolizumab saw their tumors shrink.
Memorial Sloan Kettering Cancer Center Announces Strategic Real Estate Investments
Memorial Sloan Kettering Cancer Center (MSK) today announced details of strategic real estate investments that will support the world class cancer center into the future. In March 2022, MSK announced plans to build a new, state-of-the-art cancer care Pavilion on the Upper East Side campus to address the evolving cancer care needs of patients over the next century.
MSK Awards & Appointments August 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments for August 2022.
Michael J. Morris, MD; Katherine Panageas, DrPH; Deb Schrag, MD.; and Peter D. Stetson, MD
Memorial Sloan Kettering Cancer Center Receives National Cancer Institute Grant to Establish New Telehealth Research Center
Memorial Sloan Kettering Cancer Center (MSK) today announced it has received a new grant from the National Cancer institute (NCI), part of the National Institutes of Health, under the umbrella of the Cancer Moonshot, to create the MATCHES (Making Telehealth Delivery of Cancer Care at Home Effective and Safe) Telehealth Research Center at MSK, a first of its kind.
New York Proton Center Celebrates 3rd Anniversary
The New York Proton Center (NYPC) celebrated its third anniversary, after opening its doors for treatment in August 2019.
MSK Awards & Appointments July 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
MSK's 1275 York Ave location
Memorial Sloan Kettering Cancer Center Ranked Among the Best Hospitals for Cancer Care by U.S. News & World Report for 33 Consecutive Years
Memorial Sloan Kettering Cancer Center (MSK) has been recognized as the number two hospital for cancer care in the nation by U.S. News & World Report in its annual Best Hospitals listing. Since these prestigious rankings were established more than 30 years ago, MSK has consistently ranked among the top two cancer hospitals in the country.
MSK Commack
A Gift in Memory of "Nonna": Memorial Sloan Kettering Cancer Center and the Nonna's Garden Foundation Celebrate Major Gift on Long Island
Memorial Sloan Kettering established The Nonna's Garden Foundation Initiative for Cancer Care and Research and recently renamed its first freestanding regional location on Long Island, following a generous $50 million gift from Mike and Maria Repole and the Nonna's Garden Foundation.
Dr. Selwyn M. Vickers
Dr. Selwyn M. Vickers Named President and CEO of Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center (MSK) today announced that Selwyn M. Vickers, MD, FACS, an internationally recognized pancreatic cancer surgeon and researcher, a pioneer in cancer health disparities research, and an academic medical leader, has been selected to serve as its next President and Chief Executive Officer.
MSK Awards & Appointments June 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.
Luis Alberto Diaz, Jr., MD and Andrea Cercek, MD
ASCO 2022: 100% Complete Response Rate in MMRd Locally Advanced Rectal Cancer Seen in Pivotal ‘Immunoablative’ Neoadjuvant Immunotherapy Clinical Trial
Breakthrough findings were presented at the 2022 ASCO Annual Meeting and published in The New England Journal of Medicine today by researchers at Memorial Sloan Kettering Cancer Center (MSK) confirming a clinical complete response in all 14 patients who received the immunotherapy treatment dostarlimab as a first-line treatment for mismatch repair-deficient (MMRd) locally advanced rectal cancer. This new approach of “immunoablative” therapy uses immunotherapy to replace surgery, chemotherapy and radiation to remove cancer.
Shanu Modi
ASCO 2022: Practice-Changing Findings Identify HER2-Low as a Targetable Subset of Breast Cancer, Redefining Treatment for More Than 60 Percent of HER2-Negative Metastatic Breast Cancer Patients
New data from researchers at MSK featured in the 2022 ASCO Annual Meeting press program and simultaneously published in The New England Journal of Medicine highlights a novel antibody-drug conjugate that doubled progression-free survival in HER2-low metastatic breast cancer.
Cancer Care Closer to Home: Physicians of Memorial Sloan Kettering Cancer Center and New York Cancer & Blood Specialists to Open New Cancer Care Facility in Brooklyn
Memorial Sloan Kettering Cancer Center (MSK) and New York Cancer & Blood Specialists (NYCBS), one of the fastest-growing community oncology practices in the nation, today announced plans to open a 39,000 sq ft facility in Brooklyn, New York, in early 2023.
Shanu Modi, MD, Andrea Cercek, MD, Vinod Balachandran, MD, and Jonathan Yang, MD, PhD
ASCO 2022: Memorial Sloan Kettering Cancer Center Experts To Present Significant Research at the American Society of Clinical Oncology Annual Meeting
Physicians and scientists from MSK will join oncology experts and members of the global cancer research community to present the latest advances in cancer during the 2022 ASCO Annual Meeting, June 3–7 in Chicago.
MSK Awards & Appointments May 2022
Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments:
Memorial Sloan Kettering Cancer Center Study Points to Expanded Genomic Testing That Aims To Benefit Children and Young Adults With Cancer
By sequencing the entire genome of a tumor, the experimental test will go beyond standard testing for common cancers in adults.
2022 Robbins Family Award for Nursing Excellence Winners
Celebrating Exceptional Service in Nursing at Memorial Sloan Kettering Cancer Center: Third Annual Robbins Family Awards
Memorial Sloan Kettering Cancer Center (MSK) and the Robbins Family Foundation are proud to announce today that 13 distinguished MSK nurses and one nursing team were recognized with the 2022 Robbins Family Award for Nursing Excellence. During National Nurses Week (May 6 – 12), MSK recognizes outstanding nurses for exemplary service.
The MSK Ralph Lauren Center
Ralph Lauren Corporate Foundation Announces $25 Million Commitment to Five Cancer Centers Across America With Goal of Reducing Disparities in Cancer Care in Underserved Communities 
The Ralph Lauren Corporate Foundation announced today that it's providing $25 million in new grant funding to expand or establish five Ralph Lauren cancer centers, aimed at reducing disparities in cancer care and access across underserved communities. The funding will benefit institutions including the Memorial Sloan Kettering (MSK) Ralph Lauren Center in Harlem.
Cycle for Survival
Cycle for Survival Makes History by Surpassing $300 Million for Rare Cancer Research
The Cycle for Survival community, along with founding partner, Equinox, achieves a historic fundraising milestone, fueling rare cancer research at Memorial Sloan Kettering.